Medication info
Januflo Met Extended Release Tablets 5/50/1000 mg (Dapagliflozin, Sitagliptin, Metformin)

Januflo Met Extended Release Tablets 5/50/1000 mg (Dapagliflozin, Sitagliptin, Metformin)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletSitagliptin Phosphate Hydrate›64.25mg / 1 tabletDapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Orange oval extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202401790 · Approved 2024.07.24 · Insurance code 694004300

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose is 10 mg of dapagliflozin and 100 mg of sitagliptin. The dose of extended-release metformin hydrochloride is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, take this medicine once daily with a meal, preferably in the evening. Take 1 tablet of this 10/100/1000 mg extended-release tablet once daily. Take 1 to 2 tablets of this 5/50/500 mg, 5/50/750 mg, and 5/50/1000 mg extended-release tablet once daily. To maintain the extended-release properties, swallow whole; do not split, crush, grind, or chew. Patients with renal impairment require dose adjustment according to renal function; no dose adjustment is required for patients with mild renal impairment. The dose of metformin hydrochloride may be adjusted in patients with an estimated glomerular filtration rate of 45~60 mL/min/1.73m2. The starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, and the maximum daily dose is 1000 mg. Discontinue treatment immediately if the estimated glomerular filtration rate is less than 45 mL/min/1.73m2.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes

View approved original text

This medication is used together with dapagliflozin, sitagliptin, and metformin to help control blood glucose in patients with type 2 diabetes. It serves as an adjunct to diet and exercise for those who require additional support and can effectively improve blood glucose levels. Therefore, it is recommended for patients with type 2 diabetes who are struggling with blood glucose management.

How to take

Adult dose

The dose is 10 mg of dapagliflozin and 100 mg of sitagliptin. The dose of extended-release metformin hydrochloride is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, take this medicine once daily with a meal, preferably in the evening. Take 1 tablet of this 10/100/1000 mg extended-release tablet once daily. Take 1 to 2 tablets of this 5/50/500 mg, 5/50/750 mg, and 5/50/1000 mg extended-release tablet once daily. To maintain the extended-release properties, swallow whole; do not split, crush, grind, or chew. Patients with renal impairment require dose adjustment according to renal function; no dose adjustment is required for patients with mild renal impairment. The dose of metformin hydrochloride may be adjusted in patients with an estimated glomerular filtration rate of 45~60 mL/min/1.73m2. The starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, and the maximum daily dose is 1000 mg. Discontinue treatment immediately if the estimated glomerular filtration rate is less than 45 mL/min/1.73m2.

Precautions

This medication contains three components: sitagliptin, dapagliflozin, and metformin. First, the component sitagliptin can rarely cause a serious allergic reaction. If symptoms such as skin rash or difficulty breathing occur within 3 months of administration, the use of the medication should be immediately discontinued and a physician consulted. Additionally, sitagliptin may pose a risk of acute pancreatitis, a form of inflammation of the pancreas; therefore, if abdominal pain, nausea, or vomiting arises, it should be immediately reported to a healthcare professional. Next, the dapagliflozin component carries risks of hypotension or kidney injury, especially in patients with impaired kidney function or low fluid volume. Kidney function should be thoroughly evaluated before administration, and blood pressure and kidney status should be carefully monitored during treatment. This component may also increase the risk of genital infections and urinary tract infections, necessitating prompt treatment for any signs of infection. Rarely, severe infections in the perineal area can occur; immediate medical attention is required if pain or swelling is experienced. Moreover, this medication can trigger severe metabolic disorders, known as diabetic ketoacidosis, which may present symptoms such as vomiting, abdominal pain, and difficulty breathing, even when blood sugar levels are not significantly elevated. Lastly, the metformin component, although rarely, can lead to a life-threatening condition known as lactic acidosis. Patients with impaired kidney function, heart or liver disease, or dehydration should not take this medication, and excessive alcohol intake should also be avoided. During treatment with this medication, it is important to regularly check kidney function, liver function, and vitamin B12 levels. Symptoms of hypoglycemia may occur; thus, meals should not be skipped, and caution should be exercised during exercise or when combining with other antihyperglycemic agents to prevent hypoglycemia. Additionally, if surgery is planned or if an individual is facing severe infection or dehydration, it is advisable to temporarily discontinue the medication. It is also recommended to halt administration around the time of diagnostic tests using radiographic contrast agents. This medication should not be used in certain patients, so it is crucial to accurately inform healthcare professionals about one’s health status and adhere to prescribed treatment.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • lactic acidosis
  • hypoglycemia
  • genital infections
  • vulvovaginitis
  • balanitis
Show 164 more
  • urinary tract infections
  • fungal infections
  • perineal necrosis
  • decreased fluid volume
  • thirst
  • diabetic ketoacidosis
  • dizziness
  • constipation
  • dry mouth
  • lumbar pain
  • dysuria
  • polyuria
  • nocturia
  • interstitial nephritis
  • elevated hematocrit
  • increased serum creatinine
  • dyslipidemia
  • rash
  • urosepsis
  • pyelonephritis
  • acute kidney injury
  • renal dysfunction
  • pneumonia
  • pulmonary tuberculosis
  • chest pain
  • ligament sprain
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral artery occlusion
  • angina pectoris
  • myocardial infarction
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • anaphylactic reaction
  • acute pyelonephritis
  • chest pain
  • edema
  • fever
  • foreign body sensation
  • facial swelling
  • facial pain
  • warmth
  • flu-like symptoms
  • fatigue
  • pain
  • genital rash
  • menorrhagia
  • genital edema
  • uterine bleeding
  • vaginal bleeding
  • vulvar discomfort
  • hair loss
  • dermatitis
  • dry skin
  • allergic dermatitis
  • contact dermatitis
  • diabetic foot ulcer
  • abnormal sweating eczema
  • nummular eczema
  • eczema
  • hyperkeratosis
  • nail pigmentation
  • skin lesions
  • urticaria
  • cold sweat
  • flank pain
  • fibromyalgia
  • limb discomfort
  • muscle cramps
  • musculoskeletal discomfort
  • osteopenia
  • muscle weakness
  • bruising
  • orbital fracture
  • ankle fracture
  • gastrointestinal foreign body
  • laceration
  • ligament tear
  • limb injury
  • skin abrasion
  • tendon rupture
  • thoracic spine fracture
  • tibia fracture
  • dental injury
  • dry eye
  • eye pain
  • retinal disorders
  • vision loss
  • blepharitis
  • cataract
  • conjunctival edema
  • allergic conjunctivitis
  • conjunctivitis
  • diplopia
  • eyelid edema
  • ocular hypertension
  • visual impairment
  • vitreous floaters
  • oral pharyngeal pain
  • allergic rhinitis
  • asthma
  • speech disorders
  • epistaxis
  • sputum
  • sleep apnea syndrome
  • wheezing
  • arteriosclerosis
  • flushing
  • peripheral coldness
  • varicosity
  • vascular headaches
  • orthostatic hypotension
  • atrial fibrillation
  • diastolic dysfunction
  • anxiety disorders
  • nocturia
  • auditory hallucinations
  • sleep disorders
  • insomnia
  • fatty liver
  • gallbladder polyp
  • vertigo
  • tinnitus
  • anal-genital warts
  • adenoma
  • neuroma
  • pituitary neoplasm of unspecified type
  • male reproductive gland insufficiency
  • thyroid cyst
  • thyroid nodule
  • food allergy
  • erythrocytosis
  • dyspepsia
  • nausea
  • diarrhea
  • vomiting
  • urinary retention
  • elevated alanine aminotransferase
  • elevated aspartate aminotransferase
  • decreased appetite
  • somnolence
  • headache
  • sensory loss
  • nasopharyngitis
  • myasthenia
  • hunger
  • vaginal discharge
  • itching
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • myalgia
  • osteoarthritis
  • diabetic retinopathy
  • cough
  • dyspnea
  • palpitations
  • biliary stones
  • cholangitis
  • alcoholic cirrhosis
  • liver cyst

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, ideally at room temperature between 1 and 30 degrees Celsius. By storing it this way, the medication's effectiveness can be maintained for a longer period.

Appearance and packaging

Appearance

Orange oval extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.